Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             73 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Alterations of routine blood tests in adult patients with soft tissue sarcomas: Relationships to cytokine serum levels and prognostic significance Ruka, W.

12 10 p. 1423-1432
artikel
2 Alterations of routine blood tests in adult patients with soft tissue sarcomas: Relationships to cytokine serum levels and prognostic significance W. Ruka
2001
12 10 p. 1423-1432
10 p.
artikel
3 A multicenter randomized phase II study of oral vs. intravenous vinorelbine in advanced non-small-cell lung cancer patients Jassem, J.

12 10 p. 1375-1381
artikel
4 A multicenter randomized phase II study of oral vs. intravenousvinorelbine in advanced non-small-cell lung cancer patients J. Jassem
2001
12 10 p. 1375-1381
7 p.
artikel
5 A phase II study evaluating the tolerability and efficacy of CAELYX (liposomal doxorubicin, Doxil) in the treatment of unresectable pancreatic carcinoma Halford, S.

12 10 p. 1399-1402
artikel
6 A phase II study evaluating the tolerability and efficacy of CAELYX(liposomal doxorubicin, Doxil) in the treatment of unresectablepancreatic carcinoma S. Halford
2001
12 10 p. 1399-1402
4 p.
artikel
7 A phase II study of epirubicin, cisplatin and raltitrexed combination chemotherapy (ECT) in patients with advanced oesophageal and gastric adenocarcinoma Mackay, H.J.

12 10 p. 1407-1410
artikel
8 A phase II study of epirubicin, cisplatin and raltitrexed combination chemotherapy (ECT) in patients with advanced oesophageal and gastric adenocarcinoma H. J. Mackay
2001
12 10 p. 1407-1410
4 p.
artikel
9 A phase II study of gemcitabine in gallbladder carcinoma Gallardo, J.O.

12 10 p. 1403-1406
artikel
10 A phase II study of gemcitabine in gallbladder carcinoma J. O. Gallardo
2001
12 10 p. 1403-1406
4 p.
artikel
11 Are smokers actually a bonus for the Social Security systems?
12 10 p. 1335-1338
artikel
12 Book review Biganzoli, L.

12 10 p. 1496
artikel
13 Book review Escudier, B.

12 10 p. 1497
artikel
14 Book review Ott, R.

12 10 p. 1495
artikel
15 Changed trends of cancer mortality in the elderly Levi, F.

12 10 p. 1467-1477
artikel
16 Changed trends of cancer mortality in the elderly F. Levi
2001
12 10 p. 1467-1477
11 p.
artikel
17 Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group Pectasides, D.

12 10 p. 1417-1422
artikel
18 Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group D. Pectasides
2001
12 10 p. 1417-1422
6 p.
artikel
19 Comparison of the effects of intravenous pamidronate and oral clodronate on symptoms and bone resorption in patients with metastatic bone disease Jagdev, S.P.

12 10 p. 1433-1438
artikel
20 Comparison of the effects of intravenous pamidronate and oralclodronate on symptoms and bone resorption in patients with metastaticbone disease S. P. Jagdev
2001
12 10 p. 1433-1438
6 p.
artikel
21 Contents of the next issue
12 10 p. iv
artikel
22 Copyright
12 10 p. ii
artikel
23 Corrigendum 2001
12 10 p. 1498-1498
1 p.
artikel
24 Corrigendum to: Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients
12 10 p. 1498
artikel
25 Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin’s lymphoma Machover, D.

12 10 p. 1439-1443
artikel
26 Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkins lymphoma D. Machover
2001
12 10 p. 1439-1443
5 p.
artikel
27 Diffuse large B-cell lymphoma with primary retroperitoneal presentation: Clinico-pathologic study of nine cases Piled, S.A.

12 10 p. 1445-1453
artikel
28 Diffuse large B-cell lymphoma with primary retroperitonealpresentation: Clinico-pathologic study of nine cases S. A. Pileri
2001
12 10 p. 1445-1453
9 p.
artikel
29 Editorial Board
12 10 p. iii
artikel
30 Editorial comments on ‘Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study’ Bunn Jr, P.A.

12 10 p. 1339-1340
artikel
31 Editorial comments on Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study P. A. Bunn Jr
2001
12 10 p. 1339-1340
2 p.
artikel
32 E. E. Kim & D. J. Yang (eds): Targeted Molecular Imaging in Oncology R. Ott
2001
12 10 p. 1495-1495
1 p.
artikel
33 Experience in treatment of metastatic pulmonary carcinoid tumors Granberg, D.

12 10 p. 1383-1391
artikel
34 Experience in treatment of metastatic pulmonary carcinoid tumors D. Granberg
2001
12 10 p. 1383-1391
9 p.
artikel
35 Fludarabine and mitoxantrone: Effective and well-tolerated salvage therapy in relapsed indolent lymphoproliferative disorders Seymour, J.F.

12 10 p. 1455-1460
artikel
36 Fludarabine and mitoxantrone: Effective and well-tolerated salvagetherapy in relapsed indolent lymphoproliferative disorders J. F. Seymour
2001
12 10 p. 1455-1460
6 p.
artikel
37 Freedom under attack: Terrorists hit the USA
12 10 p. 1335-1338
artikel
38 Freedom under attack: Terrorists hit the USA • Stopping the indiscriminate killers • US banned all human cloning after rejecting a plan to allow the procedure for research only, but... • Are smokers actually a bonus for the Social Security systems? • What is a correct difference in prices? • Will Novartis merge with Roche? • Mediterranean diet? Maybe, but go to Okinawa... • US patients bill of rights • Perhaps not everyone knows that... 2001
12 10 p. 1335-1338
4 p.
artikel
39 Identification of the B-cell tumor-specific molecular fingerprint using non-radiolabelled PCR consensus primers Bendandi, M.

12 10 p. 1479-1484
artikel
40 Identification of the B-cell tumor-specific molecular fingerprint using non-radiolabelled PCR consensus primers M. Bendandi
2001
12 10 p. 1479-1484
6 p.
artikel
41 In this issue
12 10 p. iv
artikel
42 J. H. Mydlo (ed): Renal Cancer, Methods and Protocols B. Escudier
2001
12 10 p. 1497-1497
1 p.
artikel
43 Mediterranean diet? Maybe, but go to Oklnawa…
12 10 p. 1335-1338
artikel
44 Metastatic malignant ameloblastoma responding to chemotherapy with paclitaxel and carboplatin Grünwald, V.

12 10 p. 1489-1491
artikel
45 Metastatic malignant ameloblastoma responding to chemotherapy withpaclitaxel and carboplatin V. Grünwald
2001
12 10 p. 1489-1491
3 p.
artikel
46 Multicenter phase II–III study of oxaliplatin plus cyclophosphamide vs. cisplatin plus cyclophosphamide in chemonaive advanced ovarian cancer patients Misset, J.-L.

12 10 p. 1411-1415
artikel
47 Multicenter phase IIIII study of oxaliplatin pluscyclophosphamide vs. cisplatin plus cyclophosphamide in chemonaiveadvanced ovarian cancer patients J.-L. Misset
2001
12 10 p. 1411-1415
5 p.
artikel
48 Pathogenesis of malignant ascites: Starling’s law of capillary hemodynamics revisited Tamsma, J.T.

12 10 p. 1353-1357
artikel
49 Pathogenesis of malignant ascites: Starlings law of capillary hemodynamics revisited J. T. Tamsma
2001
12 10 p. 1353-1357
5 p.
artikel
50 Perhaps not everyone knows that…
12 10 p. 1335-1338
artikel
51 PET and PLAP in suspected testicular cancer relapse: Beware sarcoidosis Karapetis, C.S.

12 10 p. 1485-1488
artikel
52 PET and PLAP in suspected testicular cancer relapse: Beware sarcoidosis C. S. Karapetis
2001
12 10 p. 1485-1488
4 p.
artikel
53 Prolonged neutropenia following anti CD20 therapy in a patient with relapsed follicular non-Hodgkin’s lymphoma and corrected with IVIG Saikia, T.K.

12 10 p. 1493-1494
artikel
54 Prolonged neutropenia following anti CD20 therapy in a patient with relapsed follicular non-Hodgkins lymphoma and corrected with IVIG T. K. Saikia
2001
12 10 p. 1493-1494
2 p.
artikel
55 Quality of life in patients at risk of medullary thyroid carcinoma and followed by a comprehensive medical network: Trends for future evaluations Freyer, G.

12 10 p. 1461-1465
artikel
56 Quality of life in patients at risk of medullary thyroid carcinomaand followed by a comprehensive medical network: Trends for futureevaluations G. Freyer
2001
12 10 p. 1461-1465
5 p.
artikel
57 Radon: A likely carcinogen at all exposures Darby, S.

12 10 p. 1341-1351
artikel
58 Radon: A likely carcinogen at all exposures S. Darby
2001
12 10 p. 1341-1351
11 p.
artikel
59 Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study Tjan-Heijnen, V.C.G.

12 10 p. 1359-1368
artikel
60 Reduction of chemotherapy-induced febrile leucopenia byprophylactic use of ciprofloxacin and roxithromycin in small-celllung cancer patients: An EORTC double-blind placebo-controlledphase III study V. C. G. Tjan-Heijnen
2001
12 10 p. 1359-1368
10 p.
artikel
61 S. A. Vasilev (ed): Perioperative and Supportive Care in Gynecologic Oncology: Evidence-Based Management L. Biganzoli
2001
12 10 p. 1496-1496
1 p.
artikel
62 Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin–gemcitabine–vinorelbine. A phase II study Feliu, J.

12 10 p. 1369-1374
artikel
63 Sequential therapy in advanced non-small-cell lung cancer withweekly paclitaxel followed bycisplatingemcitabinevinorelbine. A phase II study J. Feliu
2001
12 10 p. 1369-1374
6 p.
artikel
64 Stopping the indiscriminate killers
12 10 p. 1335-1338
artikel
65 Table of Contents
12 10 p. i-ii
artikel
66 US banned all human cloning after rejecting a plan to allow the procedure for research only,…
12 10 p. 1335-1338
artikel
67 Use of gemcitabine (GEM) in advanced myelodysplastic syndromes Di Mario, A.

12 10 p. 1494
artikel
68 Use of gemcitabine (GEM) in advanced myelodysplastic syndromes A. Di Mario
2001
12 10 p. 1494-1494
1 p.
artikel
69 US patients' bill of rights
12 10 p. 1335-1338
artikel
70 Weekly docetaxel (Taxotere®) in patients with metastatic breast cancer Stemmler, H.J.

12 10 p. 1393-1398
artikel
71 Weekly docetaxel (Taxotere®) in patients with metastatic breast cancer H. J. Stemmler
2001
12 10 p. 1393-1398
6 p.
artikel
72 What is a correct difference in prices?
12 10 p. 1335-1338
artikel
73 Will Novartis merge with Roche?
12 10 p. 1335-1338
artikel
                             73 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland